Nephrolithiasis is a relatively common type of disease in nephrology and is one of the most common causes of uremia in China, with 50% of patients with uremia caused by chronic nephritis. In the early stage of nephritis, proteinuria, hematuria, edema and hypertension will appear, often this is not very serious, you can intervene through drugs, the application of ACEI or ARB drugs, can effectively reduce urine protein, control blood pressure, maintain stable kidney function and prevent renal decompensation. If necessary, renal puncture can be performed to clarify the specific type of pathology, and hormone or immunosuppressive therapy can be chosen to prevent the impairment of renal function. Once the creatinine and urea are elevated, the disease is often unstoppable and will gradually progress forward to the uremic stage. At this time, the kidney can be protected by oral Bailing capsule, as well as uremic pellets to reduce creatinine symptomatic support treatment to slow down the deterioration of kidney function.